Estrella Immunopharma (ESLA) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T13:26:24.924Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:26:24.924Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -9,790,659
Quote market capitalization: 18,772,700
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 146,670

FMP input reference: 2d15fccd73dd71321fa30efb235d10704747171fee005d1a5dd6499fafc6c703

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

ESLA EBITDA Yield Metrics

EBITDA YIELD

N/A

ESLA Competitors' EBITDA Yield

ESLA

Estrella Immunopharma, Inc.

Current

Market Cap

$18.77M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs ESLA

Market Cap

$18.82M

EBITDA Yield

N/A

TTM Avg

2.57%

3Y Avg

2.17%

5Y Avg

2.17%

ACTU

Actuate Therapeutics Inc

vs ESLA

Market Cap

$20.93M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BNGO

Bionano Genomics, Inc.

vs ESLA

Market Cap

$16.58M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DYAI

Dyadic International, Inc.

vs ESLA

Market Cap

$16.54M

EBITDA Yield

N/A

TTM Avg

1.21%

3Y Avg

1.72%

5Y Avg

1.72%

BCDA

BioCardia, Inc.

vs ESLA

Market Cap

$16.22M

EBITDA Yield

N/A

TTM Avg

7.50%

3Y Avg

7.48%

5Y Avg

7.48%

ALLR

Allarity Therapeutics, Inc.

vs ESLA

Market Cap

$15.91M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs ESLA

Market Cap

$21.90M

EBITDA Yield

N/A

TTM Avg

24.06%

3Y Avg

27.42%

5Y Avg

27.42%

COCP

Cocrystal Pharma, Inc.

vs ESLA

Market Cap

$15.30M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KTTA

Pasithea Therapeutics Corp.

vs ESLA

Market Cap

$15.20M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Estrella Immunopharma, Inc. (ESLA)	$18.77M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$18.82M	N/A	2.57%	2.17%	2.17%
Actuate Therapeutics Inc (ACTU)vs ›	$20.93M	N/A	N/A	N/A	N/A
Bionano Genomics, Inc. (BNGO)vs ›	$16.58M	N/A	N/A	N/A	N/A
Dyadic International, Inc. (DYAI)vs ›	$16.54M	N/A	1.21%	1.72%	1.72%
BioCardia, Inc. (BCDA)vs ›	$16.22M	N/A	7.50%	7.48%	7.48%
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.91M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$21.90M	N/A	24.06%	27.42%	27.42%
Cocrystal Pharma, Inc. (COCP)vs ›	$15.30M	N/A	N/A	N/A	N/A
Pasithea Therapeutics Corp. (KTTA)vs ›	$15.20M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

ESLA EBITDA Yield Metrics

ESLA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics